HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rakesh K Vasishta Selected Research

Rakesh K Vasishta Research Topics

Disease

3Neoplasms (Cancer)
01/2020 - 07/2009
2Pituitary ACTH Hypersecretion
01/2019 - 01/2010
2Inflammation (Inflammations)
05/2018 - 02/2018
2Rheumatoid Arthritis
05/2018 - 02/2018
2Arthritis (Polyarthritis)
05/2018 - 02/2018
2Brain Edema (Cerebral Edema)
03/2014 - 06/2012
2Medulloblastoma
09/2012 - 04/2008
1Pituitary Neoplasms (Pituitary Adenoma)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2018
1Synovitis
02/2018
1Nervous System Diseases (Neurological Disorders)
03/2014
1Acute Liver Failure (Fulminant Hepatic Failure)
03/2014
1Optic Nerve Glioma
01/2014
1Metaplasia
01/2014
1Edema (Dropsy)
06/2012
1Granuloma
09/2011
1Portal Hypertension
09/2011
1Visceral Leishmaniasis (Kala Azar)
09/2011
1Glioblastoma (Glioblastoma Multiforme)
02/2011
1Cushing Syndrome
01/2010
1Teratoma (Teratoid Tumor)
01/2010
1Hepatocellular Carcinoma (Hepatoma)
12/2009
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
12/2009
1Embolism (Embolus)
12/2009
1Oligodendroglioma
07/2009
1Glioma (Gliomas)
07/2009
1Ankylosing Spondylitis
12/2007
1Autoimmune Diseases (Autoimmune Disease)
12/2007

Drug/Important Bio-Agent (IBA)

2Adrenocorticotropic Hormone (ACTH)FDA Link
01/2019 - 01/2010
2CollagenIBA
05/2018 - 02/2018
2CytokinesIBA
05/2018 - 02/2018
2Fibronectins (Fibronectin)IBA
05/2018 - 02/2018
2Proteins (Proteins, Gene)FDA Link
03/2014 - 12/2007
2Glial Fibrillary Acidic ProteinIBA
03/2014 - 01/2014
2Coloring Agents (Dyes)IBA
01/2014 - 12/2009
1ProlactinIBA
01/2019
1TenascinIBA
05/2018
1IronIBA
03/2018
1OsteopontinIBA
02/2018
1ThrombinFDA Link
02/2018
1Glutamic Acid (Glutamate)FDA Link
03/2014
1Excitatory Amino AcidsIBA
03/2014
1Messenger RNA (mRNA)IBA
03/2014
1Reticulin (Reticular Fiber)IBA
01/2014
1Mucin-1 (CA 15-3 Antigen)IBA
01/2014
1CateninsIBA
09/2012
1NeurotoxinsIBA
06/2012
1AmmoniaIBA
06/2012
1VaccinesIBA
09/2011
1Peptides (Polypeptides)IBA
09/2011
1DNA VaccinesIBA
09/2011
1TEMPOIBA
02/2011
1LipidsIBA
02/2011
1CyanoacrylatesIBA
12/2009
1Sclerosing Solutions (Sclerosing Agents)IBA
12/2009
1Platelet-Derived Growth FactorIBA
07/2009
1ParaffinIBA
07/2009
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2009
1Formaldehyde (Formol)FDA Link
07/2009
1Platelet-Derived Growth Factor alpha ReceptorIBA
07/2009
1Hematoxylin (Haematoxylon)IBA
04/2008
1Eosine Yellowish-(YS) (Eosin)IBA
04/2008
1Single-Chain AntibodiesIBA
12/2007
1HLA-B27 Antigen (HLA B27 Antigen)IBA
12/2007

Therapy/Procedure

3Therapeutics
01/2020 - 09/2011
1Drug Therapy (Chemotherapy)
09/2011